3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
2
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Specimen Handling
336
Magnetic Resonance Spectroscopy
332
Radiotherapy
314
Cyclophosphamide
296
pembrolizumab
283
Cisplatin
266
Carboplatin
246
Drug Therapy
237
Blood Specimen Collection
233
Biopsy
205
Bevacizumab
188
Gemcitabine
176
venetoclax
171
Radiosurgery
169
Capecitabine
165
Oxaliplatin
163
fludarabine
160
Paclitaxel
156
Nivolumab
156
Standard of Care
138
Surveys and Questionnaires
131
Surgical Procedures, Operative
131
Dexamethasone
126
Fluorouracil
125
Docetaxel
113
tislelizumab
110
Rituximab
110
Cytarabine
104
atezolizumab
101
Azacitidine
101
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
OTHER
×
AIEOP acute lymphoblastic leukemia protocol
×
Clear all
NCT06184009
2025-06-08
HR ALL
Seoul St. Mary's Hospital
Phase 2
Recruiting
370 enrolled